Veriheal
JANUARY 5, 2023
A randomized, double-blind, cross-over trial of cannabis recently published by Research Gate explored whether or not cannabidiol (CBD) — the primary non-intoxicating constituent of cannabis and hemp — improves or reduces the cannabis safety. . of the planet’s population , consuming cannabis annually.
Veriheal
JUNE 17, 2021
Research and anecdotal reports have already displayed that cannabis can be used to treat the symptoms of migraines. However, there has not been a clinical trial assessing the efficacy of cannabis for migraines, at least not until now. The First Clinical Trial for Migraines and Cannabis.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Life Network
OCTOBER 14, 2021
Cannabigerol, known as CBG, is a minor cannabinoid that became popular after companies worked around new FDA regulations placed on cannabis producers. Even as a common name, CBG had yet to undergo the same tests and clinical trials as CBD to ensure high doses are safe.
Cannabis Life Network
JULY 5, 2022
Every year sees a pile of scientific research supporting the use of cannabis as a treatment for cancer. Clinical evidence, however, has yet prove that cannabinoids, terpenes, or cannabis treat cancer. 1, 2) Before legalization in […]. 1, 2) Before legalization in […].
NORML
MAY 21, 2019
The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. CBD also showed significant protracted effects on these measures seven days after the final short-term exposure.”
Cannabis Law Report
JANUARY 11, 2023
PRESS RELEASE UK company Chanelle McCoy Health granted Ethics Approval to commence Phase III Efficacy Clinical Trial for the treatment of Sleep Disturbance CMH-CBD-001 using their Ultra Pure Synthetic Cannabinoid (CBD) formulation with pharmaceutical grade FDA registered raw material.
Cannabis Law Report
AUGUST 10, 2021
(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today reported that its subsidiary Oravax Medical Inc. Oravax”), partially owned with its majority partner Oramed Pharmaceuticals Inc.
Expert insights. Personalized for you.
96 
Let's personalize your content